Nao Fushiya

Summary

Affiliation: Jikei University School of Medicine
Country: Japan

Publications

  1. doi request reprint Genetic polymorphisms of enzymes related to oral tegafur/uracil therapeutic efficacy in patients with hepatocellular carcinoma
    Nao Fushiya
    Department of Internal Medicine, Division of Gastroenterology and Hepatology, Daisan Hospital, The Jikei University School of Medicine, Komae, Tokyo, Japan
    Anticancer Drugs 24:617-22. 2013
  2. doi request reprint Elevated plasma fibrinogen levels are associated with a poor prognosis in patients with hepatocellular carcinoma
    Akiyoshi Kinoshita
    Division of Gastroenterology and Hepatology, The Jikei University Daisan Hospital, Tokyo, Japan
    Oncology 85:269-77. 2013
  3. ncbi request reprint The addition of C-reactive protein to validated staging systems improves their prognostic ability in patients with hepatocellular carcinoma
    Akiyoshi Kinoshita
    Division of Gastroenterology and Hepatology, Jikei University Daisan Hospital, Tokyo, Japan
    Oncology 86:308-17. 2014
  4. doi request reprint The Glasgow Prognostic Score accurately predicts survival in patients with biliary tract cancer not indicated for surgical resection
    Akira Iwaku
    Division of Gastroenterology and Hepatology, The Jikei University Daisan Hospital, 4 11 1 Izumihon cho, Komae shi, Tokyo, 201 8601, Japan
    Med Oncol 31:787. 2014
  5. pmc The Glasgow Prognostic Score, an inflammation based prognostic score, predicts survival in patients with hepatocellular carcinoma
    Akiyoshi Kinoshita
    Division of Gastroenterology and Hepatology, The Jikei University Daisan Hospital, 4 11 1 Izumihon cho, Komae shi, Tokyo, 201 8601, Japan
    BMC Cancer 13:52. 2013
  6. doi request reprint Pretreatment serum C-reactive protein level predicts poor prognosis in patients with hepatocellular carcinoma
    Akiyoshi Kinoshita
    Division of Gastroenterology and Hepatology, The Jikei University Daisan Hospital, 4 11 1 Izumihon cho, Komae shi, Tokyo, 201 8601, Japan
    Med Oncol 29:2800-8. 2012

Collaborators

Detail Information

Publications6

  1. doi request reprint Genetic polymorphisms of enzymes related to oral tegafur/uracil therapeutic efficacy in patients with hepatocellular carcinoma
    Nao Fushiya
    Department of Internal Medicine, Division of Gastroenterology and Hepatology, Daisan Hospital, The Jikei University School of Medicine, Komae, Tokyo, Japan
    Anticancer Drugs 24:617-22. 2013
    ..Therefore, when administering oral 5-FU in patients with HCC, it is important to consider three genetic polymorphisms (CYP2A6, DPYD, and TS) associated with 5-FU metabolic enzymes...
  2. doi request reprint Elevated plasma fibrinogen levels are associated with a poor prognosis in patients with hepatocellular carcinoma
    Akiyoshi Kinoshita
    Division of Gastroenterology and Hepatology, The Jikei University Daisan Hospital, Tokyo, Japan
    Oncology 85:269-77. 2013
    ..Elevated plasma fibrinogen levels are associated with tumor progression and poor outcomes in cancer patients. We investigated the prognostic value of pretreatment plasma fibrinogen levels in patients with hepatocellular carcinoma (HCC)...
  3. ncbi request reprint The addition of C-reactive protein to validated staging systems improves their prognostic ability in patients with hepatocellular carcinoma
    Akiyoshi Kinoshita
    Division of Gastroenterology and Hepatology, Jikei University Daisan Hospital, Tokyo, Japan
    Oncology 86:308-17. 2014
    ..2014 S. Karger AG, Basel. ..
  4. doi request reprint The Glasgow Prognostic Score accurately predicts survival in patients with biliary tract cancer not indicated for surgical resection
    Akira Iwaku
    Division of Gastroenterology and Hepatology, The Jikei University Daisan Hospital, 4 11 1 Izumihon cho, Komae shi, Tokyo, 201 8601, Japan
    Med Oncol 31:787. 2014
    ..Our results demonstrate that the GPS is an independent marker of the prognosis in patients with BTC undergoing palliative chemotherapy or BSC, and is superior to the NLR in terms of its prognostic ability...
  5. pmc The Glasgow Prognostic Score, an inflammation based prognostic score, predicts survival in patients with hepatocellular carcinoma
    Akiyoshi Kinoshita
    Division of Gastroenterology and Hepatology, The Jikei University Daisan Hospital, 4 11 1 Izumihon cho, Komae shi, Tokyo, 201 8601, Japan
    BMC Cancer 13:52. 2013
    ..The aim of this study was to investigate the prognostic value of GPS in patients with various stages of the disease and with different liver functional status...
  6. doi request reprint Pretreatment serum C-reactive protein level predicts poor prognosis in patients with hepatocellular carcinoma
    Akiyoshi Kinoshita
    Division of Gastroenterology and Hepatology, The Jikei University Daisan Hospital, 4 11 1 Izumihon cho, Komae shi, Tokyo, 201 8601, Japan
    Med Oncol 29:2800-8. 2012
    ..Our results demonstrate that the pretreatment serum CRP level is associated with tumor progression and reduced liver function and is an independent poor prognostic marker in patients with HCC...